2025
|
Invention
|
Cbl-b inhibitor, compositions comprising a cbl-b inhibitor in a method of treating a disease asso... |
|
Invention
|
Treatment of cell proliferation-associated conditions using a combination of a clb-b inhibitor an... |
|
Invention
|
Solid forms of a triazine derivative as cbl-b modulator.
The present disclosure provides, in par... |
|
Invention
|
Methods of preparation of heterocyclic compounds.
Provided herein are methods of preparation of ... |
2024
|
Invention
|
Indazolyl-piperidine sulfonamides and related compounds and their use in therapy. The invention p... |
2023
|
Invention
|
Heterocyclic cbl-b inhibitors for the treatment of cancer. The application relates to heterocycli... |
|
Invention
|
Compounds, compositions and methods of treating disorders. The present disclose includes, among o... |
|
Invention
|
Pyrazolylcarboxamide compounds and their use in therapy. The invention provides pyrazolylcarboxam... |
|
Invention
|
Isothiazolylcarboxamide compounds and their use in therapy. The invention provides isothiazolylca... |
|
Invention
|
Pyridinylsulfonamide compounds and their use in therapy.
The invention provides pyridinylsulfona... |
|
Invention
|
Pyrazolylsulfonamide compounds and their use in therapy.
The invention provides pyrazolylsulfona... |
|
Invention
|
Pyridinylsulfonamide compounds and their use in therapy. The invention provides pyridinylsulfonam... |
|
Invention
|
Pyrazolylsulfonamide compounds and their use in therapy. The invention provides pyrazolylsulfonam... |
|
Invention
|
Solid forms of a triazine derivative as cbl-b modulator. The present disclosure provides, in part... |
|
Invention
|
Methods of preparation of heterocyclic compounds. Provided herein are methods of preparation of c... |
|
Invention
|
Cbl-b inhibitors and anti-pd1/anti-pd-l1 for use in the treatment of cancer. The present disclosu... |
2022
|
Invention
|
Compounds, compositions and methods of treating cancer.
The present disclose includes, among oth... |
|
Invention
|
Compounds, compositions and methods of treating cancer. The present disclose includes, among othe... |
2021
|
P/S
|
drug discovery services; pharmaceutical research and development services |
2018
|
P/S
|
drug discovery services; scientific research for medical purposes in the field of drug discovery ... |